Patients Were Less Satisfied With Specialized Cannabis Clinics Than With General Healthcare Settings
An Australian survey of nearly 2,400 medical cannabis patients found those attending specialized cannabis clinics were less satisfied than those treated by general healthcare providers, particularly regarding consultation time, information, and costs.
Quick Facts
What This Study Found
Of 2,394 respondents, 79.3% accessed treatment from specialized cannabis clinics (MCCs). Compared to generalist settings, MCC patients were younger, less likely to receive oral products, had higher employment and cannabis use disorder rates, and sought treatment more for mental health than chronic pain. MCC patients reported lower satisfaction with consultation duration, information about harms/benefits, discussion of other treatments, and costs.
Key Numbers
2,394 respondents; 79.3% from specialized clinics. MCC patients were 3.5 years younger on average. MCC: less likely to get oral products (OR=0.4), higher cannabis use disorder (OR=1.5), more mental health treatment (OR=1.6), less chronic pain (OR=0.7). Lower MCC satisfaction: consultation time (OR=0.8), harm/benefit info (OR=0.7), other treatment discussion (OR=0.5), costs (OR=0.6).
How They Did This
Anonymous online convenience survey of 2,394 Australian adults self-reporting prescribed medical cannabis in the preceding 12 months. Compared patient profiles, treatment patterns, and satisfaction between specialized cannabis clinics and generalist health settings.
Why This Research Matters
As commercial cannabis clinics proliferate, this study raises questions about whether the rapid-access model may trade off consultation quality. Patients in general healthcare settings reported better experiences, suggesting integration into mainstream medicine may produce better outcomes.
The Bigger Picture
The growth of specialized cannabis clinics globally raises questions about quality of care versus access. This study suggests that while these clinics increase access, they may provide less comprehensive care than traditional medical settings.
What This Study Doesn't Tell Us
Convenience sample may not represent all medical cannabis patients. Self-reported data. Cross-sectional design cannot determine if clinic type causes satisfaction differences. Unmeasured factors may explain patient differences between settings.
Questions This Raises
- ?Do specialized cannabis clinics provide adequate screening for cannabis use disorder?
- ?Would regulatory standards for consultation duration and patient education improve MCC quality?
- ?Is the generalist model scalable enough to replace specialized clinics?
Trust & Context
- Key Stat:
- Patients at general healthcare settings were 50% more likely to be satisfied with discussion of other treatment options
- Evidence Grade:
- Moderate: large survey with statistical comparisons, though convenience sampling and self-report limit generalizability.
- Study Age:
- 2025 study.
- Original Title:
- Consumer perspectives of accessing medicinal cannabis treatment from cannabis clinics versus generalist health settings in Australia.
- Published In:
- Journal of cannabis research, 7(1), 83 (2025)
- Authors:
- Lintzeris, Nicholas(19), Arnold, Jonathon C(28), McGregor, Iain S(55), Mills, Llewellyn
- Database ID:
- RTHC-06958
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Why were cannabis clinic patients less satisfied?
They reported shorter consultations, less information about harms and benefits, less discussion of alternative treatments, and higher costs compared to patients in general healthcare settings.
Did the two groups of patients differ?
Yes. Cannabis clinic patients were younger, more employed, more likely to seek treatment for mental health conditions, and had higher rates of cannabis use disorder compared to generalist setting patients.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-06958APA
Lintzeris, Nicholas; Arnold, Jonathon C; McGregor, Iain S; Mills, Llewellyn. (2025). Consumer perspectives of accessing medicinal cannabis treatment from cannabis clinics versus generalist health settings in Australia.. Journal of cannabis research, 7(1), 83. https://doi.org/10.1186/s42238-025-00338-z
MLA
Lintzeris, Nicholas, et al. "Consumer perspectives of accessing medicinal cannabis treatment from cannabis clinics versus generalist health settings in Australia.." Journal of cannabis research, 2025. https://doi.org/10.1186/s42238-025-00338-z
RethinkTHC
RethinkTHC Research Database. "Consumer perspectives of accessing medicinal cannabis treatm..." RTHC-06958. Retrieved from https://rethinkthc.com/research/lintzeris-2025-consumer-perspectives-of-accessing
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.